T here exists a strong association between the prevalence of obesity and that of hypertension.1,2 There is increasing evidence that in obese patients weight loss induced by hypocaloric diet is associated with a fall in blood pressure,3'4 although this does not reflect the experience of all investigators.5 The results of trials dealing with changes in body weight and in blood pressure remain difficult to interpret. This is mostly because a real placebo phase corresponding to the period of weight loss cannot be planned for obvious reasons. The use of ambulatory blood pressure monitoring provides an opportunity to circumvent this problem, because in contrast to the blood pressure measured by the physician in his office, blood pressure recorded in the
Although platelet cytosolic calcium has been shown to decrease during pharmacological treatment of hypertension, there is no evidence that cytosolic calcium also falls during a nonpharmacological reduction in blood pressure. To ambulatory patient does not seem to be influenced by placebo administration.6
The mechanism by which weight loss leads to a decrease in blood pressure remains unknown. In patients with essential hypertension, studies of free cytosolic calcium have suggested that abnormal calcium handling in vascular smooth muscle cells may play a role in the pathophysiology of hypertension.7-9 For example, there is good evidence that platelet cytosolic calcium falls during pharmacological reductions in blood pressure with a variety of antihypertensive agents.8 However, it is not known whether intracellular calcium falls in conjunction with nonpharmacological reductions in blood pressure.
The present trial was undertaken with the following aims in mind: 1) to investigate the effects of a 10-week nutritionally balanced, moderately hypocaloric diet on blood pressure determined not only at the physician's office but also outside the clinic using a portable blood pressure recorder and 2) to study the effects of diet-induced changes in blood pressure on free cytosolic platelet calcium, that is, to test whether it is possible to reduce free cytosolic platelet calcium by a nonpharmacological approach. blood pressure at 30-minute intervals for 12 hours while they pursued their customary activities. Decoding was always performed in blinded fashion by the same nurse, and the results were kept secret until the completion of the study.
Methods

Determination of Platelet Free Cytosolic Calcium
Platelets were isolated from citrate blood as described by Le Quan Sang and Devynck.9 Platelet free cytosolic calcium was determined using a modification of the quin 2 method.9 Briefly, the platelets were incubated for 30 minutes with 20 mol/l quin 2 (diluted in dimethyl sulfoxide) at 37°C. The quin 2-loaded platelets were diluted in a medium containing (mmol/l) NaCl 145, KCI 5, MgSO4 1, Na2HPO4 0.5, glucose 5, HEPES 10, and Ca(N03)2 1. After incubation, the cells were washed in the same medium by centrifugation.
The quin 2 fluorescence was measured in a spectrofluorometer (The Perkin-Elmer Corp., Norwalk, Conn.) at an excitation wavelength of 339 nm. For each sample, the scatter and the fluorescence spectra were recorded to check the number of platelets and the quin 2 loading Fc takes into account the fluorescence produced by the magnesium-quin 2 complex, which has been estimated to be about 20% of the measured fluorescence.
Diet Intervention
Before the diet intervention, subjects were asked to record their food intake for 1 week, with instructions to maintain their usual dietary habits. They then met individually with a dietician who, depending on the food record and the daily activity of the patient, designed a nutritionally balanced, calorierestricted diet (50% carbohydrate, 35% fat, and 15% protein), which interfered as little as possible with the subjects' food preferences. The caloric content was set with the goal of achieving a 5% reduction in BMI within 10 weeks. No instructions concerning salt intake were given. The patients were then seen at 2-week intervals by one of us for the determination of weight, blood pressure (average of three readings), and pulse rate. At the same time, the patients discussed their diet problems with the dietician. At the end of the fourth and the tenth week of diet intervention, ambulatory blood pressure recordings were repeated. After 10 weeks, blood samples were drawn, and 24-hour urine samples were collected for determination of all parameters. 
Results
Group Characteristics
Patients were classified according to their response to the diet intervention. Those achieving the preset goal of a reduction of more than 5% in BMI were considered "responders"; those achieving a smaller fall in BMI were considered "nonresponders." All baseline variables were quite comparable in the two groups of patients (Table 1) .
Two patients in the group of nonresponders and one in the group of responders withdrew from the trial before its completion. However, all data were analyzed on the basis of "intention to treat." The exit blood pressures and weights of patients who did not complete the trial were incorporated in all outcome analyses. Weight, Body Mass Index, Blood Pressure, and Free Cytosolic Platelet Calcium Figure 1 and Table 2 depict the effect of the dietary intervention on BMI, recorded and office blood pressures, and free cytosolic platelet calcium and office (---) blood pressure, and free cytosolic platelet calcium in both responders (n=19) and nonresponders (n=12) to the diet. In the responders, weight loss was accompanied by significant (*p<0.01, **p<0.o01) decreases in both office and ambulatory blood pressure. This fall in blood pressure was associated with a marked decrease in free cytosolic platelet calcium. In contrast, no significant change in these variables was observed in the nonresponders to the diet intervention.
-_ In the responders, arm circumference decreased by 2±1.5 cm (p<0.001), and heart rate fell from 83±9 to 74±10 beats/min (p<0.001), whereas no significant change in these variables was observed in the nonresponders.
At the end of the follow-up, the changes in weight, BMI, and office and recorded blood pressure were significantly more pronounced in the responders than in the nonresponders ( Table 2 ). The same was true for the changes in free cytosolic platelet calcium (p<0.001). At no moment of the study was there a significant correlation between free cytosolic platelet calcium and blood pressure (all patients before diet: The initial values of plasma renin activity and plasma catecholamines were comparable in the responders and the nonresponders (Table 3) . During the intervention period, the plasma epinephrine and norepinephrine values of responders fell (p<0.05); plasma renin activity was not significantly modified. In the nonresponders, all variables remained unchanged.
Serum electrolytes did not vary in either study group. The urinary electrolyte excretion is summarized in Table 4 . The only significant change was a decrease in sodium excretion in the responders. When comparing nonresponders to responders, sodium excretion at the beginning and the end of the trial did not differ significantly.
Total Cholesterol
In all patients together, a significant relation was observed between total plasma cholesterol and free cytosolic platelet calcium (Table 5 ). This was true both at the beginning and at the end of the study. The same kinds of correlations were observed when analyzing the results obtained in the two subgroups of patients. The coefficient of correlation achieved a significant level, however, only in the responders.
Only these patients exhibited a significant reduction in plasma cholesterol concentration during the course of the study. Discussion Although there is increasing evidence that weight reduction can be an effective treatment of hypertension, the mechanism of this antihypertensive effect is poorly understood. 15 The major new findings from the present study are twofold: 1) moderate weight reduction in overweight patients decreases blood pressure as measured by continuous ambulatory monitoring, and 2) this nonpharmacological reduction in blood pressure is accompanied by proportional decreases in platelet cytosolic calcium. These findings suggest that a fall in intracellular calcium may be an important step in nonpharmacological reductions in blood pressure.
An important feature of this study was the use of ambulatory blood pressure monitoring based on a noninvasive, semiautomatic blood pressure recorder (model M2000, Remler). In contrast to the blood pressure measured by the physician in his office, blood pressure recorded in the ambulatory patient does not seem to be influenced by placebo administration.6 This is important because it is impossible to include a true control group in a weight reduction study. Therefore, measuring only office blood pressure does not allow ruling out the possibility that the antihypertensive effect of weight reduction is partially related to a placebo effect.
The ambulatory blood pressure recordings allowed us to demonstrate that the blood pressure-lowering effects of moderate weight loss are correlated with decreases in platelet cytosolic calcium. The existence of such a relation between blood pressure reduction and decrease in platelet calcium would have been overlooked if blood pressure had been measured only in the clinic, since clinic blood pressure changes were not correlated with changes in platelet calcium. Our findings confirm previous reports showing that moderate weight reduction lowers office readings of blood pressure3,4,'6,17 and extend this observation to 12-hour ambulatory measurements of blood pressure. Patients who showed a decrease of more than 5% in BMI lowered their blood pressure by 14/5 mm Hg. To obtain this significant fall in blood pressure, patients did not have to reach their ideal body weight. Indeed, only three of the 19 responders had a normal BMI below 25 at the end of the intervention period. The average reduction in BMI of 3.01 (corresponding to an average weight loss of 8.5 kg in our responders) was, however, sufficient to restore normal office blood pressures in the majority of these overweight hypertensive patients. The reduction in body mass per se rather than a decreased salt intake is the most probable explanation for these observed decreases in blood pressure, because weight loss was associated with only small decreases in urinary sodium excretion. The observed fall in urinary sodium suggests that our patients who lost weight decreased their daily salt intake from approximately 10 to 7 g. Without weight loss, far greater reductions in dietary salt are probably needed to lower blood pressure. 18 One of the main objectives of the present study was to determine whether the diet-induced changes in blood pressure are accompanied by changes in free cytosolic platelet calcium. In the subjects who lost weight, the decreases in platelet calcium from the first to the tenth week of the diet were an order of magnitude greater than the mean intrasubject variability found in the nonresponders over this 10-week period. This finding extends previous observations819,20 that pharmacological antihypertensive treatment decreases free cytosolic platelet calcium. More importantly, it establishes the concept of a nonpharmacological reduction of free cytosolic platelet calcium and adds further evidence for the existence of some link between blood pressure regulation and intracellular calcium metabolism. The absence of a direct correlation between the level of blood pressure per se and the cytosolic concentration of ionized calcium in our study is in agreement with some21 but not other8,9,19 reports in the literature. Because of the small number of patients included in the present study and the quite small range of blood pressures observed, a weak possible correlation might have been overlooked.
Decreases in plasma levels of catecholamines, renin activity, and cholesterol in the subjects who lost weight may provide some additional clues about possible mechanisms by which weight loss decreases intracellular calcium and blood pressure. Our data confirm several previous studies'7 '22'23 showing that weight loss consistently is accompanied by a reduction in plasma epinephrine and norepinephrine levels. Because stimulation of platelet a2-adrenoceptors raises free cytosolic calcium, a fall in circulating catecholamines might have contributed to the observed decreases in platelet calcium by reducing the stimulation of these receptors. 24 The statistically significant reduction in heart rate and the tendency for plasma renin activity to fall despite decreased sodium intake provide further evidence for an attenuation of adrenergic tone during weight loss.
The significant correlation between plasma cholesterol and platelet calcium was an unexpected finding. Because the lipid content of cellular membranes has been shown to be an important determinant of cellular calcium homeostasis25'26 and LDL cholesterol per se is known to activate platelets and thereby increase intracellular calcium,27'28 it is tempting to speculate that diet-induced decreases in plasma cholesterol may have contributed to the decreases in intracellular platelet calcium in our patients.
We cannot exclude the possibility that the fall in cytosolic calcium might have been the result rather than the cause of the blood pressure reduction. A decrease in blood pressure would be expected to reduce shear forces acting on platelets, which in turn could alter platelet membrane function and, thus, cellular calcium flux. Although our clinical study has provided important information about the strength of the correlation between decreases in blood pressure and platelet calcium during weight loss, experimental studies will be needed to determine if this correlation reflects any causal relations.
